STE insider trading

NYSE Healthcare

STERIS plc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
941
Last 90 days
3
Buys / sells
0% / 27%
Market cap
$21.06B

About STERIS plc

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Company website: www.steris.com

STE insider activity at a glance

FilingIQ has scored 941 insider transactions for STE since Feb 25, 2015. The most recent filing in our index is dated Mar 5, 2026.

Across the full history, 0 open-market purchases and 257 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on STE insider trades is 64.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest STE Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

13F funds holding STE

Frequently asked

How many insider trades does FilingIQ track for STE?
FilingIQ tracks 941 Form 4 insider transactions for STE (STERIS plc), covering filings from Feb 25, 2015 onwards. 3 of those were filed in the last 90 days.
Are STE insiders net buyers or net sellers?
Across the full Form 4 history for STE, 0 transactions (0%) were open-market purchases and 257 (27%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does STE insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is STE in?
STERIS plc (STE) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $21.06B.

Methodology & sources

Every STE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.